Boragen

About:

Boragen develops synthetic chemistry platforms designed to produce next-generation fungicides.

Website: https://boragenbio.com/

Twitter/X: boragenbio

Top Investors: ARCH Venture Partners, Bill & Melinda Gates Foundation, Bayer, Alexandria Venture Investments, National Institute of Allergy and Infectious Diseases

Description:

Boragen develops synthetic chemistry platforms designed to produce next-generation fungicides. The platform supports sustainable farming methods by creating a compound that decreases the probability of fungicide resistance and reduces the amount of chemical applied while maintaining performance and efficacy. The company utilizes boron’s unique properties to design and develop novel solutions targeting needs in crop protection, animal health, and human health. Founded in 2015, Boragen is based in Durham, North Carolina.

Total Funding Amount:

$15.3M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Durham, North Carolina, United States

Founded Date:

2015-01-01

Contact Email:

info(AT)boragenbio.com

Founders:

C. Tony Liu, Gerald Fink, Lucy Shapiro, Paul Schimmel, Stephen Benkovic

Number of Employees:

1-10

Last Funding Date:

2020-07-21

IPO Status:

Private

Industries:

© 2025 bioDAO.ai